Mad Money w/ Jim Cramer Mad Money w/ Jim Cramer 2/4/26
14 snips
Feb 5, 2026 Strauss Zelnick, CEO of Take-Two Interactive, on mobile growth, catalog strength, and GTA VI timing. Ana Botín, Executive Chair of Banco Santander, on U.S. expansion, profitability and customer-focused strategy. Mike Dussault, President and CEO of Novo Nordisk, on the GLP-1 pill launch, pricing approach, and positioning versus Eli Lilly. Multiple short, focused conversations about product rollouts, strategy, and market positioning.
AI Snips
Chapters
Transcript
Episode notes
AI Fuels Market Rotation Toward Value
- AI talk is driving large parts of today's market rotation away from speculative tech and toward industrials, banks, and healthcare.
- Jim Cramer argues investors should favor individual dividend-paying, earnings-growing stocks over hype-driven high flyers.
Novo Nordisk's Rapid Pill Launch
- Mike Dussault recounts Novo Nordisk's pill launch reaching 170,000 Americans on the pill within four weeks and compares it favorably to competitors.
- He explains pricing cuts on injectables to drive volume and argues patience for volume-driven recovery.
Be Patient With Volume-Led Recovery
- Be patient with Novo Nordisk because management deliberately lowered prices to increase accessibility and expect volume to recover over time.
- Dussault explicitly asks investors to wait for volume uptake rather than judge near-term sales declines.